ADC Therapeutics S.A.
NYSE:ADCT · New York Stock Exchange
-$0.02 today
Vol 0.77M · Avg 1.68M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-59.33%
Period High
$4.88
Period Low
$0.98
Latest
$1.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alumis Inc. Common Stock
NASDAQ:ALMS
$2.85B
RAPT Therapeutics, Inc.
RAPT
$959.26M
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$889.50M
Omeros Corporation
NASDAQ:OMER
$746.91M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$503.44M
Autolus Therapeutics plc
NASDAQ:AUTL
$407.20M
Lineage Cell Therapeutics, Inc.
AMEX:LCTX
$301.65M
Bicycle Therapeutics plc
NASDAQ:BCYC
$276.88M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$275.07M
Quantum-Si incorporated
NASDAQ:QSI
$196.44M
What is the latest ADCT filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does ADCT have?
Intrinsic Alpha currently shows 20 recent filings for ADCT.
Explore More
Continue the stock analysis
Jump to another research area for this company.